US90184D1000
US90184D1000
Twist Bioscience Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 10.59B EUR | 6.45B EUR | 2.95B EUR | 1.94B EUR |
Enterprise Value | 9.48B EUR | 6.42B EUR | 2.93B EUR | 1.89B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -212.59x | -- | -- | -- |
Price to Sales | 24.53x | 14.93x | 7.21x | 6.51x |
Price to Book | 22.47x | 14.47x | 6.49x | 4.26x |
EV/Revenue | 21.95x | 14.88x | 7.15x | 6.34x |
EV/EBITDA | -82.2x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -0.61% | -1.45% | -3.22% | -3.58% |